British Columbia’s Safer Opioid Supply Policy and Opioid Outcomes.  Nguyen HV, Mital S, Bugden S, McGinty EE.  JAMA Intern Med. Published online January 16, 2024. doi:10.1001/jamainternmed.2023.7570 https://jamanetwo…

USA. ‘Addiction is a chronic medical illness that's treatable,’ and primary care physicians can help - ASAM president discusses current state of opioid crisis and how primary care could be a new avenue for physicians to connect patients to treatment…

USA. The misguided reason why providers aren’t prescribing more buprenorphine for opioid use disorder In December 2022, Congress repealed the “X-waiver” requirement, which had limited medical providers’ ability to prescribe buprenorphine-naloxone…

Differences in buprenorphine prescribing readiness among primary care professionals with and without X-waiver training in the US.  Franz B, Dhanani LY, Hall OT, Brook DL, Simon JE, Miller WC.  Harm Reduct J. 2023 Dec 21;20(1):180. doi: 1…

Telemedication for Opioid Use Disorder: A New Approach for Treatment.  Georgiadis RA, Sable P, Rosen D.  Telemed Rep. 2023 Nov 8;4(1):344-347. doi: 10.1089/tmr.2023.0036. PMID: 38098781; PMCID: PMC10719633. https://www.ncbi.nlm.nih.gov/…

Quality of life and associated factors of heroin-dependent patients receiving methadone and buprenorphine maintenance treatment.  Chang HM, Huang MC, Fang SC, Lin SK.  Neuropsychopharmacol Rep. 2023 Dec;43(4):607-615. doi: 10.1002/npr2.1…